适应和形状:转移性利基内的代谢特征
Erica Pranzini1, Luigi Ippolito1, Elisa Pardella1
1Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni, 50, 50134 Firenze, (FI), Italy.
Trends in endocrinology and metabolism: TEM
|August 9, 2024
概括
代谢因素影响癌细胞转移. 主要瘤影响远处的部位,扩散性癌细胞 (DTC) 适应其新陈代谢以生存和殖民,影响转移的成功.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 代谢过程中的代谢.
背景情况:
- 代谢因素显著影响在特定转移部位传播癌细胞 (DTC) 的成功.
- 主要瘤可以在代谢上影响远处的器官,在DTC到达之前创建一个先转移的利基.
- 此外,DTC还适应其新陈代谢以生存转移过程,并殖民目标器官.
研究的目的:
- 审查癌细胞如何与目标器官的代谢环境相互作用.
- 探索癌细胞用来塑造或适应转移的组织代谢的双重策略.
- 突出目标器官新陈代谢在转移性命运中的低估作用.
主要方法:
- 关于癌细胞代谢和转移的现有研究的文献综述.
- 分析原发性瘤,DTC和转移性微环境之间的代谢相互作用.
- 关于癌细胞对新陈代谢适应和组织成型的策略的综合发现.
主要成果:
- 癌细胞利用不同的代谢策略来殖民目标组织.
- 这些策略包括改变宿主组织的新陈代谢和调整自身的新陈代谢途径.
- 成功的殖民依赖于为瘤生长创造一个代谢上有利的环境.
结论:
- 在癌症转移的多个阶段,代谢重编程至关重要.
- 原点 (原发瘤) 和目的地 (目标器官) 都起着重要的代谢作用.
- 了解这些代谢动态为预防或治疗转移提供了潜在的治疗点.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


